Sofinnova Investments as of March 31, 2022
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 59 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Comm | 18.8 | $248M | 2.0M | 126.79 | |
| Natera Comm (NTRA) | 9.6 | $126M | 3.1M | 40.68 | |
| Cincor Pharma Comm | 7.4 | $98M | 5.6M | 17.54 | |
| Vera Therapeutics Cl A (VERA) | 5.7 | $75M | 3.2M | 23.49 | |
| Aerovate Therapeutics Comm (AVTE) | 5.2 | $69M | 3.8M | 18.33 | |
| Invesco QQQ Trust Series 1 Comm Put Option (QQQ) | 4.8 | $63M | 175k | 362.54 | |
| Ascendis Pharma A/S Adr (ASND) | 4.5 | $59M | 500k | 117.36 | |
| AstraZeneca Adr (AZN) | 2.8 | $37M | 554k | 66.34 | |
| United Therapeutics Corp Comm (UTHR) | 2.7 | $36M | 199k | 179.41 | |
| iShares Russell 2000 ETF Comm Put Option (IWM) | 2.3 | $31M | 150k | 205.27 | |
| Y-mAbs Therapeutics Comm (YMAB) | 2.0 | $26M | 2.2M | 11.88 | |
| Vertex Pharmaceuticals Comm (VRTX) | 1.9 | $25M | 95k | 260.97 | |
| Horizon Therapeutics Comm | 1.9 | $25M | 233k | 105.21 | |
| Dexcom Comm (DXCM) | 1.6 | $21M | 40k | 511.61 | |
| Regenxbio Comm (RGNX) | 1.5 | $20M | 614k | 33.19 | |
| Zoetis Comm (ZTS) | 1.5 | $20M | 107k | 188.59 | |
| Reata Pharmaceuticals Comm | 1.5 | $20M | 603k | 32.76 | |
| Sierra Oncology Comm | 1.4 | $18M | 572k | 32.05 | |
| Spdr S&P Biotech Etf Comm Put Option (XBI) | 1.4 | $18M | 200k | 89.88 | |
| Protagonist Therapeutics Comm (PTGX) | 1.3 | $18M | 747k | 23.68 | |
| Iveric Bio Comm | 1.3 | $17M | 1.0M | 16.83 | |
| Travere Therapeutics Comm (TVTX) | 1.3 | $17M | 658k | 25.77 | |
| Guardant Health Comm (GH) | 1.2 | $16M | 240k | 66.24 | |
| ChemoCentryx Comm | 1.1 | $14M | 574k | 25.07 | |
| Biomarin Pharmaceutical Comm (BMRN) | 1.0 | $14M | 177k | 77.10 | |
| Nextcure Comm (NXTC) | 1.0 | $13M | 2.7M | 4.86 | |
| Syndax Pharmaceuticals Comm (SNDX) | 0.9 | $13M | 717k | 17.38 | |
| Checkmate Pharmaceuticals Comm | 0.9 | $12M | 3.6M | 3.19 | |
| Inhibrx Comm | 0.9 | $12M | 515k | 22.28 | |
| Immatics NV Comm (IMTX) | 0.8 | $10M | 1.3M | 7.99 | |
| Jounce Therapeutics Comm | 0.8 | $10M | 1.5M | 6.79 | |
| CTI Biopharma Corp Comm | 0.7 | $9.1M | 2.0M | 4.67 | |
| Adicet Bio Comm (ACET) | 0.6 | $8.3M | 416k | 19.97 | |
| Inozyme Pharma Comm (INZY) | 0.6 | $8.3M | 2.0M | 4.09 | |
| Bolt Biotherapeutics Comm (BOLT) | 0.6 | $7.5M | 2.8M | 2.74 | |
| ChemoCentryx Call Call Option | 0.6 | $7.5M | 300k | 25.07 | |
| Galera Therapeutics Comm (GRTX) | 0.6 | $7.3M | 3.1M | 2.38 | |
| Xencor Comm (XNCR) | 0.6 | $7.3M | 274k | 26.68 | |
| Akouos Comm | 0.5 | $7.2M | 1.5M | 4.75 | |
| Bicycle Therapeutics Adr (BCYC) | 0.5 | $7.2M | 164k | 43.88 | |
| ObsEva SA Comm | 0.5 | $7.2M | 4.7M | 1.51 | |
| Sarepta Therapeutics Comm (SRPT) | 0.5 | $6.9M | 89k | 78.12 | |
| ImmunoGen Comm | 0.5 | $6.8M | 1.4M | 4.76 | |
| Nucana Adr | 0.4 | $5.6M | 5.6M | 1.00 | |
| Fulcrum Therapeutics Comm (FULC) | 0.4 | $5.4M | 230k | 23.65 | |
| Geron Corp Comm (GERN) | 0.3 | $3.9M | 2.9M | 1.36 | |
| Pfizer Comm (PFE) | 0.2 | $2.6M | 49k | 51.76 | |
| Nucana Ordinary Shares | 0.2 | $2.4M | 2.4M | 1.00 | |
| Cytokinetics Comm (CYTK) | 0.2 | $2.3M | 63k | 36.81 | |
| Intercept Pharmaceuticals Comm Call Option | 0.1 | $1.6M | 100k | 16.27 | |
| Synlogic Comm | 0.1 | $1.4M | 575k | 2.40 | |
| Amylyx Pharmaceuticals Comm (AMLX) | 0.1 | $1.3M | 100k | 12.85 | |
| PDS Biotechnology Corporation Comm (PDSB) | 0.1 | $883k | 143k | 6.19 | |
| Mink Therapeutics Comm (INKT) | 0.1 | $745k | 331k | 2.25 | |
| Fusion Pharmaceuticals Comm | 0.0 | $607k | 78k | 7.78 | |
| Insulet Corp Comm (PODD) | 0.0 | $284k | 1.1k | 266.42 | |
| PTC Therapeutics Comm (PTCT) | 0.0 | $130k | 3.5k | 37.36 | |
| Insmed Comm (INSM) | 0.0 | $126k | 5.4k | 23.47 | |
| Heron Therapeutics Comm (HRTX) | 0.0 | $63k | 11k | 5.70 |
